Search results for “Anti neoplastic” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 4,802 patents, we discovered top 444 key players by total patent application. Taiho Pharmaceutical Co., Ltd., Daiichi Sankyo Co., Ltd., Pharma Mar SA are dominant in this area. They take 8.60% of the total patent filing.
Tokyo-to, Japan
Patent: 161
New Jersey, United States
Patent: 128
Madrid, Spain
Patent: 124
Basel-Stadt, Switzerland
Patent: 85
New Jersey, United States
Patent: 85
Shanghai Shi, China
Patent: 65
Tokyo-to, Japan
Patent: 54
Indiana, United States
Patent: 53
California, United States
Patent: 43
Switzerland
Patent: 43
Startups & Unicorns
Order by:
Innovation Intensity
With the analysis among 117 patents, we discovered top 34 start-ups by total patent application. Institut National de la Santé et de la Recherche Médicale, Immunogenesis, Inc., Gensun Biopharma, Inc. are active in this area.
STARTUP
France
Patent: 20
STARTUP
Texas, United States
Patent: 14
STARTUP
California, United States
Patent: 12
STARTUP
New York, United States
Patent: 8
STARTUP
New York, United States
Patent: 8
STARTUP
California, United States
Patent: 7
STARTUP
South Korea
Patent: 5
STARTUP
California, United States
Patent: 4
STARTUP
Guangdong Sheng, China
Patent: 4
STARTUP
Chiba-ken, Japan
Patent: 3
Fast-Growing
Order by:
Innovation in recent 5 years
With the analysis among related 4,252 patents applied in the last 5 years. We discover 500 most active companies in this area. The fast-growing Taiho Pharmaceutical Co., Ltd., Shenyang Pharmaceutical University, China Pharmaceutical University take 5.60% of patent filing during this period.
Tokyo-to, Japan
Patent: 91
Liaoning Sheng, China
Patent: 75
Jiangsu Sheng, China
Patent: 72
Shanghai Shi, China
Patent: 65
New Jersey, United States
Patent: 56
Madrid, Spain
Patent: 43
Henan Sheng, China
Patent: 40
Tokyo-to, Japan
Patent: 37
Shanghai Shi, China
Patent: 35
Beijing Shi, China
Patent: 34
New Entrants
Order by:
Innovation in recent 5 years
With the analysis among related 4,252 patents in last 5 years, we discover 298 new entrants. Wigen Biomedicine technology (Shanghai) Co Ltd, Nantong University, Nektar Therapeutics are the most active new entrants in this area.
Shanghai Shi, China
Patent: 65
Jiangsu Sheng, China
Patent: 26
California, United States
Patent: 21
Shanghai Shi, China
Patent: 20
Massachusetts, United States
Patent: 19
Israel
Patent: 17
New York, United States
Patent: 17
Kansas, United States
Patent: 15
Henan Sheng, China
Patent: 15
Shandong Sheng, China
Patent: 14
Research Institutions
Order by:
Innovation Intensity
With the analysis among 3,126 patents, we discovered top 314 universities and scientific research institutions by total patent application. Shenyang Pharmaceutical University, China Pharmaceutical University, Capital University of Medical Sciences are dominant in this area. They take 8.29% of the total patent filing.
Liaoning Sheng, China
Patent: 98
Jiangsu Sheng, China
Patent: 86
Beijing Shi, China
Patent: 75
Shanghai Shi, China
Patent: 58
Henan Sheng, China
Patent: 57
Shanghai Shi, China
Patent: 50
Guangdong Sheng, China
Patent: 48
Sichuan Sheng, China
Patent: 44
Zhejiang Sheng, China
Patent: 43
United States
Patent: 36
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: